Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Fisman · SciRah

Researcher profile · Semantic Scholar

E. Fisman

Share profile

E. Fisman — researcher profile on SciRah

h-index: 44
Works: 221
Citations: 7,054

Most-cited papers

Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome.
A. Tenenbaum, M. Motro, E. Fisman, D. Tanne +2 more
2005Archives of Internal Medicine319 citations
Semantic Scholar
Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
E. Fisman, A. Tenenbaum
2014Cardiovascular Diabetology247 citations Open access
Semantic Scholar
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
A. Tenenbaum, M. Motro, E. Fisman
2005Cardiovascular Diabetology241 citations Open access
Semantic Scholar
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
A. Tenenbaum, R. Klempfner, E. Fisman
2014Cardiovascular Diabetology189 citations Open access
Semantic Scholar
Peroxisome Proliferator–Activated Receptor Ligand Bezafibrate for Prevention of Type 2 Diabetes Mellitus in Patients With Coronary Artery Disease
A. Tenenbaum, M. Motro, E. Fisman, E. Schwammenthal +6 more
2004Circulation166 citations Open access
Semantic Scholar
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
A. Tenenbaum, E. Fisman
2012Cardiovascular Diabetology165 citations Open access
Semantic Scholar
Ischemic preconditioning: nearly two decades of research. A comprehensive review.
A. Eisen, E. Fisman, M. Rubenfire, D. Freimark +4 more
2004Atherosclerosis157 citations
Semantic Scholar
Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two–Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry
R. Klempfner, A. Erez, Ben-Zekry Sagit, I. Goldenberg +5 more
2016Circulation. Cardiovascular Quality and Outcomes156 citations Open access
Semantic Scholar
Calcification of the Thoracic Aorta as Detected by Spiral Computed Tomography Among Stable Angina Pectoris Patients: Association With Cardiovascular Events and Death
A. Eisen, A. Tenenbaum, N. Koren-Morag, D. Tanne +6 more
2008Circulation141 citations Open access
Semantic Scholar
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
E. Fisman, M. Benderly, R. Esper, S. Behar +5 more
2006American Journal of Cardiology131 citations
Semantic Scholar
Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level
A. Hiuge, A. Tenenbaum, N. Maeda, M. Benderly +13 more
2007Arteriosclerosis, Thrombosis and Vascular Biology124 citations Open access
Semantic Scholar
Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
A. Tenenbaum, E. Fisman
2012Cardiovascular Diabetology107 citations Open access
Semantic Scholar
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
E. Fisman, A. Tenenbaum
2021Cardiovascular Diabetology106 citations Open access
Semantic Scholar
The ubiquitous interleukin-6: a time for reappraisal
E. Fisman, A. Tenenbaum
2010Cardiovascular Diabetology96 citations Open access
Semantic Scholar
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate.
A. Tenenbaum, E. Fisman, V. Boyko, M. Benderly +5 more
2006Archives of Internal Medicine93 citations
Semantic Scholar
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes
E. Fisman, A. Tenenbaum
2015Cardiovascular Diabetology92 citations Open access
Semantic Scholar
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients.
A. Tenenbaum, M. Motro, E. Fisman, Y. Adler +6 more
2005European Heart Journal84 citations Open access
Semantic Scholar
Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease.
A. Tenenbaum, Y. Adler, V. Boyko, H. Tenenbaum +8 more
2007American Heart Journal79 citations
Semantic Scholar
Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients
J. Shemesh, Nira Morag‐Koren, U. Goldbourt, E. Grossman +5 more
2004Journal of Hypertension66 citations
Semantic Scholar
Spiral computed tomography evidence of close correlation between coronary and thoracic aorta calcifications.
Y. Adler, E. Fisman, J. Shemesh, E. Schwammenthal +4 more
2004Atherosclerosis66 citations
Semantic Scholar
Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery
A. Kogan, E. Ram, S. Levin, E. Fisman +3 more
2018Cardiovascular Diabetology65 citations Open access
Semantic Scholar
"The metabolic syndrome... is dead": These reports are an exaggeration
A. Tenenbaum, E. Fisman
2011Cardiovascular Diabetology60 citations Open access
Semantic Scholar
C-Reactive Protein as a Predictor of Incident Ischemic Stroke Among Patients With Preexisting Cardiovascular Disease
D. Tanne, M. Benderly, U. Goldbourt, M. Haim +6 more
2006Stroke57 citations Open access
Semantic Scholar
Functional class in patients with heart failure is associated with the development of diabetes.
A. Tenenbaum, M. Motro, E. Fisman, J. Leor +6 more
2003American Journal of Medicine55 citations
Semantic Scholar
Cardiovascular diabetology: clinical, metabolic and inflammatory facets. Preface.
E. Fisman, A. Tenenbaum
2008Advances in Cardiology51 citations
Semantic Scholar
Macrovascular complications of metabolic syndrome: an early intervention is imperative.
A. Tenenbaum, M. Motro, E. Schwammenthal, E. Fisman
2004International Journal of Cardiology48 citations
Semantic Scholar
Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
A. Tenenbaum, E. Fisman, M. Motro, Y. Adler
2008Advances in Cardiology45 citations
Semantic Scholar
Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease
A. Younis, A. Younis, B. Tzur, Y. Peled +5 more
2016Cardiovascular Diabetology44 citations Open access
Semantic Scholar
Impaired Glucose Metabolism in Patients with Heart Failure
A. Tenenbaum, E. Fisman
2004American Journal of Cardiovascular Drugs44 citations
Semantic Scholar
Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus
A. Tenenbaum, E. Fisman, E. Schwammenthal, Y. Adler +3 more
2003Cardiovascular Diabetology44 citations Open access
Semantic Scholar
Biomarkers in cardiovascular diabetology: interleukins and matrixins.
E. Fisman, Y. Adler, A. Tenenbaum
2008Advances in Cardiology43 citations
Semantic Scholar
Left ventricular diastolic function in trained male weight lifters at rest and during isometric exercise.
Y. Adler, E. Fisman, N. Koren-Morag, D. Tanne +3 more
2008American Journal of Cardiology42 citations
Semantic Scholar
Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome.
M. Feinberg, R. Schwartz, D. Tanne, E. Fisman +6 more
2007American Journal of Cardiology40 citations
Semantic Scholar
"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study
A. Tenenbaum, E. Fisman
2010Cardiovascular Diabetology38 citations Open access
Semantic Scholar
Calcification of the thoracic aorta by spiral computed tomography among hypertensive patients: associations and risk of ischemic cerebrovascular events.
D. Tanne, A. Tenenbaum, J. Shemesh, Y. Schwammenthal +3 more
2007International Journal of Cardiology38 citations
Semantic Scholar
Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes.
H. Tenenbaum, S. Behar, V. Boyko, Y. Adler +8 more
2007Atherosclerosis37 citations
Semantic Scholar
Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial
Y. Arbel, R. Klempfner, A. Erez, I. Goldenberg +4 more
2016Cardiovascular Diabetology36 citations Open access
Semantic Scholar
Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up
E. Fisman, M. Motro, A. Tenenbaum, J. Leor +5 more
2004European Journal of Cardiovascular Prevention & Rehabilitation35 citations
Semantic Scholar
Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
Osnat Itzhaki Ben Zadok, R. Kornowski, I. Goldenberg, R. Klempfner +9 more
2017Cardiovascular Diabetology31 citations Open access
Semantic Scholar
The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study
A. Younis, Dana Eskenazi, R. Goldkorn, J. Leor +5 more
2017Cardiovascular Diabetology31 citations Open access
Semantic Scholar
Oral Antidiabetic Therapy in Patients with Heart Disease
E. Fisman, A. Tenenbaum, M. Motro, Y. Adler
2004Herz31 citations
Semantic Scholar
Long-term versus intermediate-term supervised exercise training in advanced heart failure: effects on exercise tolerance and mortality.
A. Tenenbaum, D. Freimark, Ella Ahron, N. Koren-Morag +7 more
2006International Journal of Cardiology28 citations
Semantic Scholar
Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery
E. Ram, L. Sternik, R. Klempfner, Z. Iakobishvili +5 more
2020Cardiovascular Diabetology27 citations Open access
Semantic Scholar
Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
A. Tenenbaum, D. Medvedofsky, E. Fisman, L. Bubyr +5 more
2012PLoS ONE27 citations Open access
Semantic Scholar
Renal glucosuria is associated with lower body weight and lower rates of elevated systolic blood pressure: results of a nationwide cross-sectional study of 2.5 million adolescents
B. Fishman, G. Shlomai, G. Twig, E. Derazne +4 more
2019Cardiovascular Diabetology26 citations Open access
Semantic Scholar
Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation
E. Ram, J. Lavee, A. Tenenbaum, R. Klempfner +6 more
2019Cardiovascular Diabetology25 citations Open access
Semantic Scholar
Temporal trends in management and outcome of diabetic and non-diabetic patients with acute coronary syndrome (ACS): residual risk of long-term mortality persists: Insights from the ACS Israeli Survey (ACSIS) 2000-2010.
R. Klempfner, A. Elis, S. Matezky, G. Keren +7 more
2015International Journal of Cardiology25 citations
Semantic Scholar
Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects
A. Milwidsky, E. Maor, S. Kivity, A. Berkovitch +8 more
2015Cardiovascular Diabetology25 citations Open access
Semantic Scholar
Glucagon like peptide-1 (GLP-1) agonists and cardiometabolic protection: historical development and future challenges
F. Westermeier, E. Fisman
2025Cardiovascular Diabetology24 citations Open access
Semantic Scholar
Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease
R. Klempfner, J. Leor, A. Tenenbaum, E. Fisman +1 more
2012Cardiovascular Diabetology24 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Tenenbaum×49
Invite
A. Tenenbaum — researcher profile on SciRah
M. Motro×19
Invite
M. Motro — researcher profile on SciRah
Y. Adler×19
Invite
Y. Adler — researcher profile on SciRah
D. Tanne×15
Invite
D. Tanne — researcher profile on SciRah

×12

Invite

S. Behar — researcher profile on SciRah

R. Klempfner×11

Invite

R. Klempfner — researcher profile on SciRah

I. Goldenberg×10

Invite

I. Goldenberg — researcher profile on SciRah

Invite

V. Boyko — researcher profile on SciRah

E. Schwammenthal×8

Invite

E. Schwammenthal — researcher profile on SciRah

Invite

J. Shemesh — researcher profile on SciRah

Invite

J. Leor — researcher profile on SciRah

Invite

Z. Matas — researcher profile on SciRah